Abstract
The data from this study suggest that more patients develop skin malignancies than previously reported from Europe. It is important to advise patients before transplantation in regard to skin complications, provide regular dermatological follow-up, and tailor immunosuppressive regimen to minimum doses to be compatible with good graft function.
Original language | English |
---|---|
Pages (from-to) | 574-579 |
Number of pages | 6 |
Journal | Transplantation |
Volume | 77 |
Issue number | 4 |
DOIs | |
Publication status | Published - 2004 |